[{"address1": "2625 Townsgate Road", "address2": "Suite 230", "city": "Westlake Village", "state": "CA", "zip": "91361", "country": "United States", "phone": "805 267 9889", "website": "https://www.genelux.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Zindrick J.D.", "age": 65, "title": "Chairman, CEO & President", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 570990, "exercisedValue": 0, "unexercisedValue": 11528577}, {"maxAge": 1, "name": "Dr. Joseph  Cappello Ph.D.", "age": 67, "title": "Chief Technical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 213077, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean  Ryder J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 380000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yong  Yu Ph.D.", "age": 53, "title": "Senior Vice President of Clinical Development", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 242615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Paul  Scigalla M.D., Ph.D.", "age": 79, "title": "Chief Medical Officer", "yearBorn": 1945, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ralph  Smalling B.Sc.", "age": 67, "title": "VP & Head of Regulatory Affairs", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.82, "open": 4.84, "dayLow": 4.65, "dayHigh": 5.1229, "regularMarketPreviousClose": 4.82, "regularMarketOpen": 4.84, "regularMarketDayLow": 4.65, "regularMarketDayHigh": 5.1229, "payoutRatio": 0.0, "beta": -1.51, "forwardPE": -5.0531917, "volume": 116431, "regularMarketVolume": 116431, "averageVolume": 216744, "averageVolume10days": 326970, "averageDailyVolume10Day": 326970, "bid": 3.51, "ask": 6.06, "bidSize": 2, "askSize": 2, "marketCap": 164056448, "fiftyTwoWeekLow": 1.6, "fiftyTwoWeekHigh": 8.668, "priceToSalesTrailing12Months": 20507.057, "fiftyDayAverage": 3.2754, "twoHundredDayAverage": 2.7575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 132367384, "profitMargins": 0.0, "floatShares": 25998811, "sharesOutstanding": 34538200, "sharesShort": 1866176, "sharesShortPriorMonth": 1625415, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.054, "heldPercentInsiders": 0.16633, "heldPercentInstitutions": 0.14156, "shortRatio": 7.02, "shortPercentOfFloat": 0.0641, "impliedSharesOutstanding": 34538200, "bookValue": 0.97, "priceToBook": 4.896907, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -27660000, "trailingEps": -0.94, "forwardEps": -0.94, "enterpriseToRevenue": 16545.924, "enterpriseToEbitda": -4.616, "52WeekChange": -0.27736133, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 4.75, "targetHighPrice": 30.0, "targetLowPrice": 8.0, "targetMeanPrice": 18.4, "targetMedianPrice": 19.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 34057000, "totalCashPerShare": 0.999, "ebitda": -28676000, "totalDebt": 2039000, "quickRatio": 6.131, "currentRatio": 6.475, "totalRevenue": 8000, "debtToEquity": 6.162, "revenuePerShare": 0.0, "returnOnAssets": -0.48675, "returnOnEquity": -0.96849996, "grossProfits": 8000, "freeCashflow": -13646875, "operatingCashflow": -23836000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -3618.625, "financialCurrency": "USD", "symbol": "GNLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.4522856, "regularMarketPrice": 4.75, "corporateActions": [], "regularMarketTime": 1740170550, "exchange": "NCM", "messageBoardId": "finmb_11172383", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Genelux Corporation", "longName": "Genelux Corporation", "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1674743400000, "regularMarketChange": -0.07000017, "regularMarketDayRange": "4.65 - 5.1229", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 216744, "fiftyTwoWeekLowChange": 3.15, "fiftyTwoWeekLowChangePercent": 1.96875, "fiftyTwoWeekRange": "1.6 - 8.668", "fiftyTwoWeekHighChange": -3.9180002, "fiftyTwoWeekHighChangePercent": -0.45200738, "fiftyTwoWeekChangePercent": -27.736134, "epsTrailingTwelveMonths": -0.94, "epsForward": -0.94, "epsCurrentYear": -0.8875, "priceEpsCurrentYear": -5.352113, "fiftyDayAverageChange": 1.4746001, "fiftyDayAverageChangePercent": 0.45020458, "twoHundredDayAverageChange": 1.9925001, "twoHundredDayAverageChangePercent": 0.72257483, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-01-26", "cryptoTradeable": false, "displayName": "Genelux", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]